IJPM is a clinical personalized-medicine journal that also includes basic, molecular, biomarker and translational research.
IJPM is a clinical personalized-medicine journal that also includes basic, molecular, biomarker and translational research. It considers work in the areas below, and clinical studies of diagnosis, treatment and patient management are in scope.
Studies of diagnosis, treatment and patient management that apply personalized and precision approaches.
Genetic, proteomic, metabolomic and genomic markers of susceptibility, drug response and outcome, with analytical and cohort validation.
Multi-omic characterization and signatures for patient stratification.
Variants that affect drug metabolism, efficacy and toxicity.
Sequencing assays, liquid biopsy and other molecular testing platforms, and the development of new assays.
Statistical and machine-learning models built on clinical and molecular data.
Mechanistic studies that underpin individualized care.
Work that carries discovery into clinical application, including biostatistics and regulatory science.
These areas are illustrative. Read the full Aims and Scope.
IJPM publishes the article types listed here. Requirements for each type are set out in the Instructions for Authors.
All submissions undergo editorial screening. Manuscripts that meet the journal's scope and minimum requirements proceed to independent peer review. Single-blind by default; double-blind review is available on request. Manuscripts that proceed to external peer review are normally evaluated by at least two independent subject-matter experts.
Reference information on the journal's ownership, editorial responsibility, rights, review, fees and preservation.
Please read the Instructions for Authors and the Editorial Policies before submitting. The article processing charge of USD 1,200 is payable only after acceptance; withdrawal after submission is subject to the journal's withdrawal policy.
Questions about a submission: info@openaccesspub.org